Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05428839 · ClinicalTrials.gov registry record · NA
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
A NA study of Sleep Apnea, Obstructive, sponsored by Inspire Medical Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 10
- Study locations
NCT05428839: Recruiting NA study of Sleep Apnea, Obstructive, sponsored by Inspire Medical Systems.
NCT05428839 is a NA study of Sleep Apnea, Obstructive that is actively recruiting participants, run by Inspire Medical Systems. The registered enrollment target is 300 participants, above the 256-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (17% higher). The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05428839, a NA study of Sleep Apnea, Obstructive, is actively recruiting participants, sponsored by Inspire Medical Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is an exploratory, multicenter study of up to 300 subjects diagnosed with obstructive sleep apnea who are being evaluated for airway surgery. Subjects will undergo standard evaluation for airway surgery as part of standard of care. In addition to the standard airway assessment, a simple, non-invasive measurement of the width of the inside of each subjects mouth will be performed. This measurement takes 2-3 minutes to perform.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pharyngeal width measurement
Study Locations (10)
Pennsylvania
- University of Pennsylvania - Philadelphia
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Arizona
- Valley ENT - Scottsdale
Illinois
- Rush University Medical Center - Chicago
Iowa
- Mason City Clinic - Mason City
Massachusetts
- Massachusetts Eye and Ear Infirmary - Boston
Minnesota
- ENT Specialty Care of MN - Saint Louis Park
Ohio
- Ohio State University - Columbus
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-05-11 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
What NCT05428839 shows while recruiting
NCT05428839 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 256-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (17% higher).
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Pharyngeal width measurement is the first listed.
NCT05428839 lists 10 locations in 8 states (Pennsylvania, Arizona, Illinois).
Frequently Asked Questions
What is clinical trial NCT05428839 about?
NCT05428839 is a clinical study titled "The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea". This study is an exploratory, multicenter study of up to 300 subjects diagnosed with obstructive sleep apnea who are being evaluated for airway surgery. Subjects will undergo standard evaluation for airway surgery as part of standard of care. In addition to the standard airway assessment, a simple, ...
What is the current status of trial NCT05428839?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-05-11. Estimated completion is 2025-01-31.
What conditions does trial NCT05428839 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT05428839?
The interventions under investigation include: Pharyngeal width measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05428839?
This trial is sponsored by Inspire Medical Systems, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05428839 being conducted?
This trial has 10 study locations across Arizona, Illinois, Iowa, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05428839's enrollment target sits among peer trials
300 11th of 45 higher than 35 of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
-
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
RECRUITING · NA
-
Long-term Evaluation of a Nasopharyngeal Airway
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI